182 related articles for article (PubMed ID: 27845349)
41. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults.
Cheng AC; Stephens DP; Currie BJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD004400. PubMed ID: 17443546
[TBL] [Abstract][Full Text] [Related]
42. Lack of beneficial effects of granulocyte colony-stimulating factor in patients with subacute myocardial infarction undergoing late revascularization: a double-blind, randomized, placebo-controlled clinical trial.
Karimabad HM; Shabestari M; Baharvand H; Vosough A; Gourabi H; Shahverdi A; Shamsian A; Abdolhoseini S; Moazzami K; Moradi Marjaneh M; Emami F; Bidkhori HR; Hamedanchi A; Talebi S; Farrokhi F; Jabbari-Azad F; Fadavi M; Garivani U; Mahmoodi M; Aghdami N
Acta Cardiol; 2011 Apr; 66(2):219-24. PubMed ID: 21591581
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial.
Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Yamauchi T; Mannoji C; Miyashita T; Kadota R; Hashimoto M; Ito Y; Takahashi K; Koda M
Eur Spine J; 2012 Dec; 21(12):2580-7. PubMed ID: 22391867
[TBL] [Abstract][Full Text] [Related]
44. G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia.
Lu CZ; Xiao BG
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1327-33. PubMed ID: 17073813
[TBL] [Abstract][Full Text] [Related]
45. Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial.
Steppich B; Hadamitzky M; Ibrahim T; Groha P; Schunkert H; Laugwitz KL; Kastrati A; Ott I;
Thromb Haemost; 2016 Apr; 115(4):864-8. PubMed ID: 26790705
[TBL] [Abstract][Full Text] [Related]
46. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials.
Marot A; Singal AK; Moreno C; Deltenre P
JHEP Rep; 2020 Oct; 2(5):100139. PubMed ID: 32775975
[TBL] [Abstract][Full Text] [Related]
47. Tirilazad for acute ischaemic stroke.
Bath PM; Iddenden R; Bath FJ; Orgogozo JM;
Cochrane Database Syst Rev; 2001; (4):CD002087. PubMed ID: 11687138
[TBL] [Abstract][Full Text] [Related]
48. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
49. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
50. Strategies to improve post-stroke behavioral recovery in aged subjects.
Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
[TBL] [Abstract][Full Text] [Related]
51. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
[TBL] [Abstract][Full Text] [Related]
52. Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial.
Chih S; Macdonald PS; McCrohon JA; Ma D; Moore J; Feneley MP; Law M; Kovacic JC; Graham RM
Heart; 2012 Feb; 98(4):282-90. PubMed ID: 22115984
[TBL] [Abstract][Full Text] [Related]
53. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
[TBL] [Abstract][Full Text] [Related]
54. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
55. Granulocyte Colony-Stimulating Factor Attenuates Blood-Brain Barrier Damage and Improves Cognitive Function in Spontaneously Hypertensive Rats.
Wei X; Xu Y; Jin Y; Feng H; Xiao Y; Dong S
CNS Neurol Disord Drug Targets; 2017; 16(7):781-788. PubMed ID: 28176642
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.
Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Jacquy C; Burniat A; Steels E; Vallot F; Sculier JP
Support Care Cancer; 2002 Apr; 10(3):181-8. PubMed ID: 11904782
[TBL] [Abstract][Full Text] [Related]
57. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
[TBL] [Abstract][Full Text] [Related]
58. New missions for an old agent: granulocyte-colony stimulating factor in the treatment of stroke patients.
Solaroglu I; Digicaylioglu M; Keles GE; Zhang JH
Curr Med Chem; 2015; 22(10):1302-9. PubMed ID: 25666797
[TBL] [Abstract][Full Text] [Related]
59. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
Bohlius J; Reiser M; Schwarzer G; Engert A
Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
[TBL] [Abstract][Full Text] [Related]
60. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
